Diabetes, Obesity and Metabolism

SJR Rank #1,126H-index: 169SJR: 2.273Best quartile: Q1APC: US$5,380
Journal website: aims, scope and author guidelines
Publisher

John Wiley and Sons Inc

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.61.21.82.4

Subject Categories

  • EndocrinologyQ1
  • Endocrinology, Diabetes and MetabolismQ1
  • Internal MedicineQ1

Areas: Biochemistry, Genetics and Molecular Biology · Medicine

Most published research topics

Diabetes Treatment and ManagementDiabetes Management and ResearchDiabetes, Cardiovascular Risks, and LipoproteinsPancreatic function and diabetesMetabolism, Diabetes, and CancerBariatric Surgery and OutcomesHyperglycemia and glycemic control in critically ill and hospitalized patientsDiabetes and associated disordersDiet and metabolism studiesPharmacology and Obesity Treatment

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs035070010501400

Documents per Year

2022202502505007501000

Detailed Information

ISSN

1463-1326, 1462-8902

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

5.71

References per Document

41.44

Coverage

1999-2026

Scope

Diabetes, Obesity and Metabolism is primarily a journal of clinical and experimental pharmacology and therapeutics covering the interrelated areas of diabetes, obesity and metabolism. The journal prioritises high-quality original research that reports on the effects of new or existing therapies, including dietary, exercise and lifestyle (non-pharmacological) interventions, in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems. ‘Metabolism’ may relate to lipids, bone and drug metabolism, or broader aspects of endocrine dysfunction. Preclinical pharmacology, pharmacokinetic studies, meta-analyses and those addressing drug safety and tolerability are also highly suitable for publication in this journal. Original research may be published as a main paper or as a research letter.

Metrics from SCImago Journal Rank 2025. View on SCImago